Ignite Creation Date:
2025-12-24 @ 12:54 PM
Ignite Modification Date:
2026-01-06 @ 9:00 AM
Study NCT ID:
NCT05821361
Status:
UNKNOWN
Last Update Posted:
2023-04-20
First Post:
2023-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-07
First Submit QC Date:
None
Study First Post Date:
2023-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-07
Last Update Post Date:
2023-04-20
Last Update Post Date Type:
ACTUAL